vs
Side-by-side financial comparison of MAGNACHIP SEMICONDUCTOR Corp (MX) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
MAGNACHIP SEMICONDUCTOR Corp is the larger business by last-quarter revenue ($40.6M vs $20.4M, roughly 2.0× Sight Sciences, Inc.). MAGNACHIP SEMICONDUCTOR Corp runs the higher net margin — -19.9% vs -20.4%, a 0.5% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -20.7%). Sight Sciences, Inc. produced more free cash flow last quarter ($-2.0M vs $-4.8M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs -3.4%).
Magnachip Semiconductor Corp is a global semiconductor design and manufacturing firm specializing in high-performance analog and mixed-signal solutions. Its core products include display driver ICs, power management ICs and sensors, serving consumer electronics, automotive, industrial and communications markets worldwide.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
MX vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.6M | $20.4M |
| Net Profit | $-8.1M | $-4.2M |
| Gross Margin | 9.3% | 87.3% |
| Operating Margin | -26.1% | -18.0% |
| Net Margin | -19.9% | -20.4% |
| Revenue YoY | -20.7% | 6.9% |
| Net Profit YoY | 50.4% | 64.9% |
| EPS (diluted) | $-0.23 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $40.6M | $20.4M | ||
| Q3 25 | $45.9M | $19.9M | ||
| Q2 25 | $47.6M | $19.6M | ||
| Q1 25 | $44.7M | $17.5M | ||
| Q4 24 | $51.2M | $19.1M | ||
| Q3 24 | $55.4M | $20.2M | ||
| Q2 24 | $46.4M | $21.4M | ||
| Q1 24 | $43.4M | $19.3M |
| Q4 25 | $-8.1M | $-4.2M | ||
| Q3 25 | $-13.1M | $-8.2M | ||
| Q2 25 | $323.0K | $-11.9M | ||
| Q1 25 | $-8.9M | $-14.2M | ||
| Q4 24 | $-16.3M | $-11.8M | ||
| Q3 24 | $-9.6M | $-11.1M | ||
| Q2 24 | $-13.0M | $-12.3M | ||
| Q1 24 | $-15.4M | $-16.3M |
| Q4 25 | 9.3% | 87.3% | ||
| Q3 25 | 18.6% | 86.4% | ||
| Q2 25 | 20.4% | 84.8% | ||
| Q1 25 | 20.9% | 86.2% | ||
| Q4 24 | 21.7% | 86.8% | ||
| Q3 24 | 20.8% | 83.9% | ||
| Q2 24 | 21.1% | 85.8% | ||
| Q1 24 | 14.6% | 85.5% |
| Q4 25 | -26.1% | -18.0% | ||
| Q3 25 | -25.1% | -39.7% | ||
| Q2 25 | -15.6% | -59.6% | ||
| Q1 25 | -14.1% | -79.2% | ||
| Q4 24 | -12.5% | -62.5% | ||
| Q3 24 | -8.1% | -55.7% | ||
| Q2 24 | -12.3% | -59.2% | ||
| Q1 24 | -21.6% | -76.4% |
| Q4 25 | -19.9% | -20.4% | ||
| Q3 25 | -28.5% | -41.0% | ||
| Q2 25 | 0.7% | -61.0% | ||
| Q1 25 | -19.9% | -80.8% | ||
| Q4 24 | -31.8% | -62.1% | ||
| Q3 24 | -17.3% | -54.9% | ||
| Q2 24 | -28.0% | -57.7% | ||
| Q1 24 | -35.5% | -84.4% |
| Q4 25 | $-0.23 | $-0.07 | ||
| Q3 25 | $-0.36 | $-0.16 | ||
| Q2 25 | $0.01 | $-0.23 | ||
| Q1 25 | $-0.24 | $-0.28 | ||
| Q4 24 | $-0.44 | $-0.23 | ||
| Q3 24 | $-0.26 | $-0.22 | ||
| Q2 24 | $-0.34 | $-0.25 | ||
| Q1 24 | $-0.40 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.8M | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $248.3M | $63.9M |
| Total Assets | $351.5M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $103.8M | $92.0M | ||
| Q3 25 | $108.0M | $92.4M | ||
| Q2 25 | $113.3M | $101.5M | ||
| Q1 25 | $132.7M | $108.8M | ||
| Q4 24 | $138.6M | $120.4M | ||
| Q3 24 | $151.1M | $118.6M | ||
| Q2 24 | $162.5M | $118.2M | ||
| Q1 24 | $171.6M | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $248.3M | $63.9M | ||
| Q3 25 | $255.3M | $64.3M | ||
| Q2 25 | $270.2M | $70.0M | ||
| Q1 25 | $269.2M | $77.6M | ||
| Q4 24 | $276.8M | $87.5M | ||
| Q3 24 | $299.6M | $95.0M | ||
| Q2 24 | $305.8M | $101.6M | ||
| Q1 24 | $321.9M | $109.2M |
| Q4 25 | $351.5M | $115.3M | ||
| Q3 25 | $359.6M | $116.3M | ||
| Q2 25 | $370.5M | $122.0M | ||
| Q1 25 | $373.9M | $129.7M | ||
| Q4 24 | $379.3M | $142.8M | ||
| Q3 24 | $411.4M | $143.6M | ||
| Q2 24 | $412.7M | $149.7M | ||
| Q1 24 | $426.2M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $-1.8M |
| Free Cash FlowOCF − Capex | $-4.8M | $-2.0M |
| FCF MarginFCF / Revenue | -11.9% | -9.7% |
| Capex IntensityCapex / Revenue | 25.3% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-54.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.4M | $-1.8M | ||
| Q3 25 | $162.0K | $-8.7M | ||
| Q2 25 | $-25.1M | $-7.5M | ||
| Q1 25 | $-4.7M | $-11.6M | ||
| Q4 24 | $11.9M | $-3.5M | ||
| Q3 24 | $-12.9M | $362.0K | ||
| Q2 24 | $-1.1M | $-9.5M | ||
| Q1 24 | $-4.0M | $-9.8M |
| Q4 25 | $-4.8M | $-2.0M | ||
| Q3 25 | $-7.5M | $-8.9M | ||
| Q2 25 | $-37.0M | $-7.8M | ||
| Q1 25 | $-4.9M | — | ||
| Q4 24 | $4.4M | $-3.6M | ||
| Q3 24 | $-15.5M | $311.0K | ||
| Q2 24 | $-2.0M | $-9.5M | ||
| Q1 24 | $-4.6M | $-9.9M |
| Q4 25 | -11.9% | -9.7% | ||
| Q3 25 | -16.3% | -44.7% | ||
| Q2 25 | -77.7% | -39.6% | ||
| Q1 25 | -10.9% | — | ||
| Q4 24 | 8.7% | -18.9% | ||
| Q3 24 | -28.0% | 1.5% | ||
| Q2 24 | -4.3% | -44.7% | ||
| Q1 24 | -10.7% | -51.4% |
| Q4 25 | 25.3% | 0.8% | ||
| Q3 25 | 16.7% | 0.9% | ||
| Q2 25 | 24.9% | 1.1% | ||
| Q1 25 | 0.5% | 0.0% | ||
| Q4 24 | 14.5% | 0.7% | ||
| Q3 24 | 4.7% | 0.3% | ||
| Q2 24 | 1.9% | 0.4% | ||
| Q1 24 | 1.5% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -77.81× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MX
| Power Analog Solutions | $36.8M | 91% |
| Power Ic | $3.8M | 9% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
